CIK 0001676725 · Large accelerated filer
IDEAYA Biosciences, Inc.
Sign in to watch- Ticker
- IDYA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474268251
- Phone
- 650-443-6209
- Business address
- 5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $985,397
- in 1 filing, $985K under 10b5-1 plans
Net −$985,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 67 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-14 | Ruiz Briseno Andres See Remarks | Sale 10b5-1 | −1,672 | $34.00 | $57K | 30,859 |
| 2023-12-14 | Ruiz Briseno Andres See Remarks | Sale 10b5-1 | −328 | $34.01 | $11K | 30,531 |
| 2023-11-03 | Throne Jason Chief Legal Officer | Option exercise 10b5-1 | +5,163 | $12.86 | $66K | 5,163 |
| 2023-11-03 | Throne Jason Chief Legal Officer | Sale 10b5-1 | −5,163 | $30.09 | $155K | 0 |
| 2023-11-03 | Throne Jason Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,163 | 48,750 | ||
| 2023-09-12 | Throne Jason Chief Legal Officer | Option exercise 10b5-1 | +1,000 | $12.86 | $13K | 1,000 |
| 2023-09-12 | Throne Jason Chief Legal Officer | Sale 10b5-1 | −500 | $30.00 | $15K | 500 |
| 2023-09-12 | Throne Jason Chief Legal Officer | Sale 10b5-1 | −500 | $30.01 | $15K | 0 |
| 2023-09-12 | Throne Jason Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,000 | 53,913 | ||
| 2023-09-05 | Throne Jason Chief Legal Officer | Option exercise 10b5-1 | +1,737 | $12.86 | $22K | 1,737 |
| 2023-09-05 | Throne Jason Chief Legal Officer | Sale 10b5-1 | −1,737 | $30.03 | $52K | 0 |
| 2023-09-05 | Throne Jason Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,737 | 54,913 | ||
| 2023-09-01 | Throne Jason Chief Legal Officer | Option exercise 10b5-1 | +2,100 | $12.86 | $27K | 2,100 |
| 2023-09-01 | Throne Jason Chief Legal Officer | Sale 10b5-1 | −2,100 | $30.03 | $63K | 0 |
| 2023-09-01 | Throne Jason Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,100 | 56,650 | ||
| 2023-09-01 | Ruiz Briseno Andres See Remarks | Sale 10b5-1 | −2,000 | $30.01 | $60K | 32,531 |
| 2023-08-29 | Stone Paul A. Chief Financial Officer | Sale 10b5-1 | −5,000 | $28.87 | $144K | 9,303 |
| 2023-08-21 | Stone Paul A. Chief Financial Officer | Sale 10b5-1 | −978 | $26.40 | $26K | 14,303 |
| 2023-08-18 | Stone Paul A. Chief Financial Officer | Sale 10b5-1 | −3,822 | $26.38 | $101K | 15,281 |
| 2023-08-16 | Stone Paul A. Chief Financial Officer | Sale 10b5-1 | −100 | $26.45 | $3K | 19,203 |
Page 6 of 10 · 186 trades